234 related articles for article (PubMed ID: 31127089)
1. Brain-derived neurotrophic factor as a possible predictor of electroconvulsive therapy outcome.
van Zutphen EM; Rhebergen D; van Exel E; Oudega ML; Bouckaert F; Sienaert P; Vandenbulcke M; Stek M; Dols A
Transl Psychiatry; 2019 May; 9(1):155. PubMed ID: 31127089
[TBL] [Abstract][Full Text] [Related]
2. Association between the novel seizure quality index for the outcome prediction in electroconvulsive therapy and brain-derived neurotrophic factor serum levels.
Kranaster L; Hellweg R; Sartorius A
Neurosci Lett; 2019 Jun; 704():164-168. PubMed ID: 30978454
[TBL] [Abstract][Full Text] [Related]
3. BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients.
Maffioletti E; Gennarelli M; Gainelli G; Bocchio-Chiavetto L; Bortolomasi M; Minelli A
J ECT; 2019 Sep; 35(3):189-194. PubMed ID: 30994478
[TBL] [Abstract][Full Text] [Related]
4. Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorder.
Sorri A; Järventausta K; Kampman O; Lehtimäki K; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E
Brain Behav; 2018 Nov; 8(11):e01101. PubMed ID: 30273985
[TBL] [Abstract][Full Text] [Related]
5. Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF).
Freire TF; Fleck MP; da Rocha NS
Brain Res Bull; 2016 Mar; 121():263-9. PubMed ID: 26892396
[TBL] [Abstract][Full Text] [Related]
6. Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression.
Vanicek T; Kranz GS; Vyssoki B; Fugger G; Komorowski A; Höflich A; Saumer G; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
Brain Stimul; 2019; 12(4):1041-1050. PubMed ID: 31000384
[TBL] [Abstract][Full Text] [Related]
7. Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients.
Fernandes B; Gama CS; Massuda R; Torres M; Camargo D; Kunz M; Belmonte-de-Abreu PS; Kapczinski F; de Almeida Fleck MP; Inês Lobato M
Neurosci Lett; 2009 Apr; 453(3):195-8. PubMed ID: 19429034
[TBL] [Abstract][Full Text] [Related]
8. Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia.
Li J; Ye F; Xiao W; Tang X; Sha W; Zhang X; Wang J
Eur Psychiatry; 2016 Aug; 36():23-8. PubMed ID: 27311104
[TBL] [Abstract][Full Text] [Related]
9. Repetitive enhancement of serum BDNF subsequent to continuation ECT.
Vanicek T; Kranz GS; Vyssoki B; Komorowski A; Fugger G; Höflich A; Micskei Z; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
Acta Psychiatr Scand; 2019 Nov; 140(5):426-434. PubMed ID: 31369144
[TBL] [Abstract][Full Text] [Related]
10. Relationship Between Hippocampal Volume, Serum BDNF, and Depression Severity Following Electroconvulsive Therapy in Late-Life Depression.
Bouckaert F; Dols A; Emsell L; De Winter FL; Vansteelandt K; Claes L; Sunaert S; Stek M; Sienaert P; Vandenbulcke M
Neuropsychopharmacology; 2016 Oct; 41(11):2741-8. PubMed ID: 27272769
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study.
Okamoto T; Yoshimura R; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Inoue Y; Ueda N; Nakamura J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1185-90. PubMed ID: 18403081
[TBL] [Abstract][Full Text] [Related]
12. Brain-Derived Neurotrophic Factor in the Cerebrospinal Fluid Increases During Electroconvulsive Therapy in Patients With Depression: A Preliminary Report.
Mindt S; Neumaier M; Hellweg R; Sartorius A; Kranaster L
J ECT; 2020 Sep; 36(3):193-197. PubMed ID: 32118691
[TBL] [Abstract][Full Text] [Related]
13. BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy.
Ryan KM; Dunne R; McLoughlin DM
Brain Stimul; 2018; 11(5):1123-1131. PubMed ID: 29802070
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression.
Marano CM; Phatak P; Vemulapalli UR; Sasan A; Nalbandyan MR; Ramanujam S; Soekadar S; Demosthenous M; Regenold WT
J Clin Psychiatry; 2007 Apr; 68(4):512-7. PubMed ID: 17474805
[TBL] [Abstract][Full Text] [Related]
15. Electroconvulsive therapy improves clinical manifestation with plasma BDNF levels unchanged in treatment-resistant depression patients.
Lin CH; Chen MC; Lee WK; Chen CC; Huang CH; Lane HY
Neuropsychobiology; 2013; 68(2):110-5. PubMed ID: 23881232
[TBL] [Abstract][Full Text] [Related]
16. RETRACTED: Electroconvulsive therapy and aerobic exercise training increased BDNF and ameliorated depressive symptoms in patients suffering from treatment-resistant major depressive disorder.
Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Kirov R; Holsboer-Trachsler E; Brand S
J Psychiatr Res; 2014 Oct; 57():117-24. PubMed ID: 25073431
[TBL] [Abstract][Full Text] [Related]
17. BDNF blood levels after electroconvulsive therapy in patients with mood disorders: a systematic review and meta-analysis.
Brunoni AR; Baeken C; Machado-Vieira R; Gattaz WF; Vanderhasselt MA
World J Biol Psychiatry; 2014 Jul; 15(5):411-8. PubMed ID: 24628093
[TBL] [Abstract][Full Text] [Related]
18. Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder.
Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Holsboer-Trachsler E; Brand S
J Psychiatr Res; 2016 May; 76():1-8. PubMed ID: 26859236
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with major depressive disorder: A systematic review and meta-analysis.
Luan S; Zhou B; Wu Q; Wan H; Li H
Asian J Psychiatr; 2020 Jun; 51():101983. PubMed ID: 32146142
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor and electroconvulsive therapy in a schizophrenic patient with treatment-resistant paranoid-hallucinatory symptoms.
Martinotti G; Ricci V; Di Nicola M; Caltagirone C; Bria P; Angelucci F
J ECT; 2011 Mar; 27(1):e44-6. PubMed ID: 21206369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
